Similar articles

• Oseltamivir (Tamiflu) for pandemic influenza in India: some issues.

  Singh AA. Singh AA. Natl Med J India. 2009 Mar-Apr;22(2):103. Natl Med J India. 2009. PMID: 19852352 No abstract available.
• Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.

  Baz M, Abed Y, Papenburg J, Bouhy X, Hamelin ME, Boivin G. Baz M, et al. N Engl J Med. 2009 Dec 3;361(23):2296-7. doi: 10.1056/NEJMc0910060. Epub 2009 Nov 11. N Engl J Med. 2009. PMID: 19907034 No abstract available.
• Oseltamivir-induced resistant pandemic A/H1N1 influenza virus in a child with cystic fibrosis and Pseudomonas aeruginosa infection.

  Esposito S, Molteni CG, Colombo C, Daleno C, Daccò V, Lackenby A, Principi N. Esposito S, et al. J Clin Virol. 2010 May;48(1):62-5. doi: 10.1016/j.jcv.2010.02.019. Epub 2010 Mar 23. J Clin Virol. 2010. PMID: 20335065
• The use of antiviral agents for the management of severe influenza.

  Smith JR, Ariano RE, Toovey S. Smith JR, et al. Crit Care Med. 2010 Apr;38(4 Suppl):e43-51. doi: 10.1097/CCM.0b013e3181c85229. Crit Care Med. 2010. PMID: 19935416 Review.
• More resistance to oseltamivir (Tamiflu).

  [No authors listed] [No authors listed] Med Lett Drugs Ther. 2009 Jan 26;51(1304):5-6. Med Lett Drugs Ther. 2009. PMID: 19172138 Review. No abstract available.